This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Anti-hypertensive therapy and risk of type II diabetes

Authoring team

This prospective open trial investigated whether antihypertensive treatment increases the risk of developing type 2 diabetes.

12550 adults aged 45 to 64 years were given a health evaluation. 3804 were defined as hypertensive because of raised blood pressure (systolic > 140 mmHg or diastolic > 80 mmHg) or the consumption of antihypertensive medication.

Antihypertensive medications used in the trial were thiazide diuretics, beta-blockers, calcium channel blockers and ACE inhibitors. Individuals were followed up at 3 and 6 years.

Reference:

  • (1) Todd W. Gress, F. Javier Nieto, Eyal Shahar, Marion R. Wofford, Frederick L. Brancati, for the Atherosclerosis Risk in Communities Study. (2000) Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. N Engl J Med. 342, 905-12.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.